Carpal Tunnel Release Systems Market to Exceed US$ 1,036.4 Million by 2035, Driven by Minimally Invasive Advances and Aging Population – Latest Report by Transparency Market Research Inc. ...
CONMED Corporation (CNMD)
Last conmed corporation earnings: 4/29 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
conmed.com/en/about-us/investors/investor-relations
Company Research
Source: Yahoo! Finance
invasive surgery and an aging population drive demand for safer, more efficient surgical solutions. Wilmington, Delaware, Transparency Market Research Inc. – , Feb. 26, 2025 (GLOBE NEWSWIRE) -- The global carpal tunnel release systems market (Weltmarkt für Karpaltunnel-Release-Systeme), valued at approximately US$ 612.3 million in 2024 , is projected to expand at a CAGR of 4.9% from 2025 to 2035 , crossing the US$ 1,036.4 million mark by the end of the forecast period. The burgeoning market is primarily driven by rapid technological advancements in minimally invasive surgery and an increasing elderly population that is more susceptible to musculoskeletal disorders. Carpal Tunnel Release (CTR) Systems—medical devices and instruments designed to alleviate pressure on the median nerve within the wrist—have become indispensable in the treatment of Carpal Tunnel Syndrome (CTS). This condition, characterized by pain, numbness, and tingling in the hand and fingers, often necessitates a
Show less
Read more
Impact Snapshot
Event Time:
CNMD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CNMD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CNMD alerts
High impacting CONMED Corporation news events
Weekly update
A roundup of the hottest topics
CNMD
News
- CONMED (NYSE:CNMD) had its price target lowered by analysts at Bank of America Corporation from $65.00 to $52.00. They now have a "neutral" rating on the stock.MarketBeat
- CONMED Corporation Announces Strategic Exit from Gastroenterology Product LinesBusiness Wire
- CONMED (NYSE:CNMD) had its price target lowered by analysts at JPMorgan Chase & Co. from $58.00 to $52.00. They now have a "neutral" rating on the stock.MarketBeat
- CONMED (NYSE:CNMD) had its price target lowered by analysts at Piper Sandler from $68.00 to $55.00. They now have an "overweight" rating on the stock.MarketBeat
- CONMED (NYSE:CNMD) had its price target lowered by analysts at Wells Fargo & Company from $57.00 to $47.00. They now have an "equal weight" rating on the stock.MarketBeat
CNMD
Earnings
- 11/5/25 - Beat
CNMD
Sec Filings
- 12/5/25 - Form 8-K
- 11/24/25 - Form 4
- 11/21/25 - Form 4
- CNMD's page on the SEC website